ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Medarex

Include trials that are no longer recruiting patients.

4 studies were found.
1.CompletedComparison Study of MDX-010 (CTLA-4) Alone and Combined with Docetaxel in the Treatment of Patients with Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
2.CompletedComparison Study of MDX-010 (CTLA-4) Alone and Combined with DTIC in the Treatment of Metastatic Melanoma
Condition: Melanoma
3.RecruitingMDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients with Melanoma
Conditions: Melanoma; Metastases
4.No longer recruitingStudy of MDX-010 in Stage IV Breast Cancer
Conditions: Breast Cancer; Adenocarcinoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act